Korczynski Sherry, Chief Commercial Officer was awarded 42,500 shares of Aquestive Therapeutics, Inc. ($AQST) @ $4.29 ($182,325.00 total) on Mar 9, 2026

Korczynski Sherry – Chief Commercial Officer

Mar 9, 2026

52W Low$2.12

Current$3.9834.3% above low, 65.7% below high

Purchase$4.2940.0% above low, 60.0% below high

52W High$7.55

42,500

Price

$4.29

Total Value

$182,325.00

Nearby Earnings

Mar 4, 2026

EPS:Est: -0.13

Revenue:Est: $13.28M

Insider	Korczynski Sherry
Title	Chief Commercial Officer
Transaction Date	Mar 9, 2026
Expiration Date	Mar 9, 2036
Transaction Code	A Grant/Award
Acquired/Disposed	Acquired
Security	Non-Qualified Stock Option (right to buy) (Common Stock)
Derivative	Yes
Direct/Indirect	Direct
Filing Date	Mar 11, 2026
Shares Purchased	42,500
Price per Share	$4.29
Total Value	$182,325.00
Shares Owned After	42,500
Derivative	Derivative (Common Stock)
Accession Number	0001214659-26-003142
Document	View SEC Filing